Related Experiment Video
Updated: Apr 28, 2026

04:33
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
1.8K
Managing major depression: improving the interface between psychiatrists and primary care.
International Journal of Psychiatry in Clinical Practice
|June 18, 2014
Summary
Primary care settings struggle with major depressive disorder (MDD) management due to low recognition and poor follow-up. Collaborative care models integrating mental health specialists significantly improve patient outcomes and satisfaction.
Area of Science:
- Psychiatry
- Primary Care Medicine
- Mental Health Services Research
Background:
- Major depressive disorder (MDD) management predominantly occurs in primary care.
- Current primary care practices for MDD suffer from low recognition rates, inadequate treatment, and poor follow-up, leading to suboptimal patient care.
- Primary care education alone has not demonstrated long-term benefits for MDD patients.
Purpose of the Study:
- To evaluate the impact of collaborative care models on the management of major depressive disorder in primary care settings.
- To assess the effectiveness of integrating mental health specialists into primary care for improving patient outcomes and satisfaction.
Main Methods:
- Review of studies examining collaborative care models in primary care for MDD.
- Analysis of the impact of psychiatrist-primary care collaboration on patient management and adherence to guidelines.
- Assessment of patient and physician satisfaction with collaborative care interventions.
Main Results:
- Stronger collaboration between psychiatrists and primary care significantly enhances the quality of care for MDD patients.
- Simple collaborative care models have a dramatic positive impact on patient outcomes.
- These models also significantly enhance satisfaction for both patients and physicians.
Conclusions:
- Collaborative care models, integrating mental health specialists into primary care, are highly effective for managing major depressive disorder.
- These interventions can be cost-effectively implemented broadly to improve MDD management standards in primary care.
- Widespread adoption of collaborative care can make effective MDD management the norm, not the exception, in primary care settings.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Community Based Intervention
617
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
617
Acute Coronary Syndrome IV: Interprofessional Care
522
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Depression: Overview
1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
Depressive Disorders: MDD and Dysthymia
1.2K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.2K
Psychosis: Goals of Pharmacotherapy
699
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
699

